| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Wells Donna | Director | C/O WALKER & DUNLOP, INC., 7272 WISCONSIN AVENUE, SUITE 1300, BETHESDA | /s/ Nicholas C. Eckstein, Attorney-in-fact | 17 Mar 2026 | 0001613921 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WD | Common Stock | Options Exercise | +1,381 | +26% | $0.000000* | 6,658 | 13 Mar 2026 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | WD | Deferred Stock Units | Options Exercise | -1,381 | -100% | $0.000000* | 0 | 13 Mar 2026 | Common Stock | 1,381 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Each deferred stock unit represents the right to receive one share of common stock of the Issuer. |
| F2 | The deferred stock units are fully vested and were settled in shares of the Issuer's common stock on March 13, 2026 pursuant to the Issuer's Deferred Compensation Plan for Non-Employee Directors. |